APA

Lillibridge J. H., Liang B. H., Kerr B. M., Webber S., Quart B., Shetty B. V. & Lee C. A. (19980824). Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Lillibridge J H, Liang B H, Kerr B M, Webber S, Quart B, Shetty B V and Lee C A. 19980824. Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Lillibridge J. H., Liang B. H., Kerr B. M., Webber S., Quart B., Shetty B. V. and Lee C. A. (19980824). Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Lillibridge J H, Liang B H, Kerr B M, Webber S, Quart B, Shetty B V and Lee C A. Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. : Drug metabolism and disposition: the biological fate of chemicals. 19980824.